A small amount of 2mg Fentanyl can be deadly. As a result, illicit Fentanyl has become a potential health hazard to industries such as pre-hospital patient care, law enforcement, investigation & evidence handling, special operations & decontamination according to NIOSH.
Read More >>
Majority of the public are not aware of the factors that cause hypersensitivity. The general perception is that by wearing gloves, the issues of hypersensitivity will be solved. Unfortunately, this is not the case as specific allergens or chemicals found in gloves can also cause hypersensitivity such as Type I Hypersensitivity (latex protein allergy), Type IV Hypersensitivity (delayed contact dermatitis) and Irritant Contact Dermatitis (local irritation cause by irritants). The cause of hypersensitivity or allergic reactions can be so complex it is difficult for glove users to find a solution to their current damaged skin.
This claim indicates that the glove product demonstrates reduced potential for sensitising glove users to chemical additives. However not all glove users are sensitised to the same or common types of chemical additives. As a result, U.S. FDA makes it compulsory to include a WARNING statement "Do not use this product if you have a known allergy to chemical additives." on the glove packaging to ensure sensitised glove users are not unintentionally harmed by other types of chemical additives.
Read More >>
Gloves used as a protection against chemotherapy drugs exposure must be selected specifically for the type of drugs being used. As a glove user, you must always refer to the chemotherapy drugs permeation data and Material Safety Data Sheet provided to you by the glove company upon request to determine the glove-use suitability.
Disposable gloves are for single-use only. Reusing the gloves increases the risk of contamination and infection even if the used-gloves have been washed before the next use. Cleaning process may also weaken the glove’s barrier performance, increasing the tendency of puncture and tearing of the glove. In order to be safe, avoid reusing the gloves and always inspect each glove after donning for punctures or tears. Replace the gloves if they are to contain defects.
Both Proposition 65 under the California Safe Drinking Water & Toxic Enforcement Act 1986 and REACH under the EU Regulation enforce conditions and/or restrictions on the use of harmful chemical additives that are hazardous to health and the environment (eg. cause cancer, birth defects, reproductive harm, bio-accumulative). In order to provide an all-round protection to glove users, LOW DERMA™ Technology enhanced nitrile examination gloves is complied with and will continue to comply to such regulations.
The United States Food & Drugs Administration (U.S. FDA) labelling requires products that underwent additional clinical test (Modified Draize-95 Test) to be labelled as ‘Low Dermatitis Potential’(test subject demonstrated reduced potential for sensitising users to chemical additives). Although the product is essentially ‘accelerator-free’, U.S. FDA guidelines specify ‘accelerator-free’ as misbranding. 'Accelerator-free' is not accurate because it is not possible to absolutely and reliably assure that there is an absence of accelerators in the medical product. LOW DERMA™ enhanced nitrile gloves have been shown to fulfill all the requirements set forth in the 510(k) Premarket Notification and become the first to be granted by U.S. FDA on ‘Low Dermatitis Potential’. Thus, this modern LOW DERMA™ Technology becomes the solution to rectify glove-induced skin sensitivity faced by countless professionals, safeguarding their profession in the long term.
Sulphur is used as a crosslinking agent in rubber materials to enhance its strength and elastic property which is essential for glove’s barrier protection. Chemical Accelerators (Thiurams, Thiazoles and Carbamates) are added in the glove manufacturing process to accelerate the crosslinking reaction in achieving the desired properties.
A patented technology of its class used in nitrile gloves to eliminates the use of Sulphur & Chemical Accelerators in the conventional manufacturing process. LOW DERMA™ Technology, with its unique crosslinking ability can provide a solution that ensures low dermatitis potential through purer and cleaner gloves. LOW DERMA™ nitrile gloves also exhibit significant ability to ensure uncompromised tear strength and elasticity while providing desirable softness and comfort. Furthermore, LOW DERMA™ attributes are supported by various tests performed by accredited laboratories that meet the requirements of international regulatory bodies.
The most commonly done allergic tests are skin tests. A small amount of suspected allergens are put on skin to observe for any sign of reaction. The suspected allergens may be taped to the skin (Patch test) or they may be applied via a small prick to the skin (Prick test). Doctors normally use Patch Test to conduct allergic test on patients. (small skin surface will be exposed to the types of allergens present in the patch, that potentially induce allergic reactions). The patch will remain on the skin for two days and doctors will then check for signs of skin reactions under the patch to decide if further test is required. Please note that different country may term the test or have test methods that varied from the above.
You can look out for the round LOW DERMA™ logo with the tagline “Technology in Skin Protection” strategically positioned on Top and/or at the Side (Long or Short) Panel of the glove packaging/dispenser box. You can also find this website link www.lowderma.com/patents printed on the glove packaging/dispenser that you purchased.
Low Derma Identity Guideline >>